Last reviewed · How we verify
KRRO-110
At a glance
| Generic name | KRRO-110 |
|---|---|
| Sponsor | Korro Bio, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110 (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KRRO-110 CI brief — competitive landscape report
- KRRO-110 updates RSS · CI watch RSS
- Korro Bio, Inc. portfolio CI